Difference between revisions of "ENDO5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo...")
 
 
(7 intermediate revisions by the same user not shown)
Line 6: Line 6:
  
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 +
 +
__TOC__
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Endocrine and Neuroendocrine Tumours (5th Edition) Content</big>
 
|+<big>WHO Classification of Endocrine and Neuroendocrine Tumours (5th Edition) Content</big>
Line 17: Line 19:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|
 +
==== CHAPTER 2 (PITUITARY TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Somatotroph_PitNET/adenoma|Somatotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 51:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mammosomatotroph_PitNET/adenoma|Mammosomatotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 62:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Lactotroph_PitNET/adenoma|Lactotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 73:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyrotroph_PitNET/adenoma|Thyrotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 84:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mature_plurihormonal_PIT1-lineage_PitNET/adenoma|Mature plurihormonal PIT1-lineage PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 95:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Immature_PIT1-lineage_PitNET/adenoma|Immature PIT1-lineage PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 106:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Acidophil_stem_cell_PitNET/adenoma|Acidophil stem cell PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 117:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mixed_somatotroph-lactotroph_PitNET/adenoma|Mixed somatotroph-lactotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 128:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Corticotroph_PitNET/adenoma|Corticotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 139:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Gonadotroph_PitNET/adenoma|Gonadotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 150:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Null_cell_PitNET/adenoma|Null cell PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 161:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Plurihormonal_PitNET/adenomas|Plurihormonal PitNET/adenomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 172:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Multiple_synchronous_PitNET/adenomas_of_distinct_lineages|Multiple synchronous PitNET/adenomas of distinct lineages]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 183:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Metastatic_PitNET|Metastatic PitNET]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 194:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 205:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 216:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Pituitary_blastoma|Pituitary blastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 227:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Pituicytomas|Pituicytomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 238:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Gangliocytoma_and_mixed_gangliocytoma-PitNET/adenoma|Gangliocytoma and mixed gangliocytoma-PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 249:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Sellar_neurocytoma|Sellar neurocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 260:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Meningiomas|Meningiomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 271:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Chordoma|Chordoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 282:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 3 (THYROID TUMOURS) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroglossal_duct_cyst|Thyroglossal duct cyst]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 314:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Other_congenital_thyroid_abnormalities|Other congenital thyroid abnormalities]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 325:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroid_follicular_nodular_disease|Thyroid follicular nodular disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 336:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Follicular_thyroid_adenoma|Follicular thyroid adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 347:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Follicular_thyroid_adenoma_with_papillary_architecture|Follicular thyroid adenoma with papillary architecture]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 358:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Oncocytic_adenoma_of_the_thyroid|Oncocytic adenoma of the thyroid]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 369:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Non-invasive_follicular_thyroid_neoplasm_with_papillary-like_nuclear_features|Non-invasive follicular thyroid neoplasm with papillary-like nuclear features]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 380:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroid_tumours_of_uncertain_malignant_potential|Thyroid tumours of uncertain malignant potential]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 391:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Hyalinizing_trabecular_tumour|Hyalinizing trabecular tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 402:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Follicular_thyroid_carcinoma|Follicular thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 413:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Invasive_encapsulated_follicular_variant_of_papillary_thyroid_carcinoma|Invasive encapsulated follicular variant of papillary thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 424:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Papillary_thyroid_carcinoma|Papillary thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 435:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Oncocytic_carcinoma_of_the_thyroid|Oncocytic carcinoma of the thyroid]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 446:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:High-grade_follicular_cell-derived_non-anaplastic_thyroid_carcinoma|High-grade follicular cell-derived non-anaplastic thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 457:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Anaplastic_thyroid_carcinoma|Anaplastic thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 468:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Medullary_thyroid_carcinoma|Medullary thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 479:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mixed_medullary_and_follicular_cell-derived_thyroid_carcinomas|Mixed medullary and follicular cell-derived thyroid carcinomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 490:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 501:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Secretory_carcinoma|Secretory carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 512:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Sclerosing_mucoepidermoid_carcinoma_with_eosinophilia|Sclerosing mucoepidermoid carcinoma with eosinophilia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 523:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Cribriform_morular_thyroid_carcinoma|Cribriform morular thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 534:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thymoma|Thymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 545:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Spindle_epithelial_tumour_with_thymus-like_elements|Spindle epithelial tumour with thymus-like elements]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 556:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Intrathyroidal_thymic_carcinoma|Intrathyroidal thymic carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 567:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroblastoma|Thyroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 578:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 4 (PARATHYROID TUMOURS) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_hyperplasia|Parathyroid hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 468: Line 610:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_adenoma|Parathyroid adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 621:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_lipoadenoma|Parathyroid lipoadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 632:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Atypical_parathyroid_tumour|Atypical parathyroid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 643:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_carcinoma|Parathyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 654:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 5 (ADRENAL GLAND TUMOURS) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_rests|Adrenal rests]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 686:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_cysts|Adrenal cysts]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 697:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_myelolipoma|Adrenal myelolipoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 708:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Congenital_adrenal_hyperplasia|Congenital adrenal hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 719:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenocortical_nodular_disease|Adrenocortical nodular disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 558: Line 730:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_cortical_adenoma|Adrenal cortical adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 741:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_cortical_carcinoma|Adrenal cortical carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 752:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_sex_cord_stromal_tumour|Adrenal sex cord stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 763:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adenomatoid_tumour|Adenomatoid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 774:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_melanoma|Adrenal melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 785:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
 
 
|
 
|
 +
==== CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Neuroblastoma|Neuroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 817:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Ganglioneuroblastoma,_intermixed|Ganglioneuroblastoma, intermixed]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 828:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Ganglioneuroblastoma,_nodular|Ganglioneuroblastoma, nodular]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 839:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Ganglioneuroma|Ganglioneuroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 850:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Phaeochromocytoma|Phaeochromocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 861:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Sympathetic_paraganglioma|Sympathetic paraganglioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 872:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parasympathetic_paraganglioma|Parasympathetic paraganglioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 883:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Composite_phaeochromocytomas_and_paragangliomas|Composite phaeochromocytomas and paragangliomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 894:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|
 +
==== CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Non-functioning_(non-syndromic)_pancreatic_neuroendocrine_tumours|Non-functioning (non-syndromic) pancreatic neuroendocrine tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 926:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Insulinoma|Insulinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 937:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Glucagonoma|Glucagonoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 948:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Somatostatinoma|Somatostatinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 959:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Gastrinoma|Gastrinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 970:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:VIPoma|VIPoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 981:
 
|
 
|
 
|-
 
|-
 +
|[[ENDO5:Serotonin-producing_tumours_with_and_without_carcinoid_syndrome|Serotonin-producing tumours with and without carcinoid syndrome]]
 +
|Disease
 +
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Other_pancreatic_neuroendocrine_tumours_with_ectopic_hormone_production|Other pancreatic neuroendocrine tumours with ectopic hormone production]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Pancreatic_neuroendocrine_carcinoma|Pancreatic neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Mixed_ductal_adenocarcinoma-neuroendocrine_neoplasms|Mixed ductal adenocarcinoma-neuroendocrine neoplasms]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Mixed_acinar-neuroendocrine_carcinoma|Mixed acinar-neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Neuroendocrine_tumours|Neuroendocrine tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Merkel_cell_carcinoma|Merkel cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Mixed_neuroendocrine-non-neuroendocrine_neoplasms|Mixed neuroendocrine-non-neuroendocrine neoplasms]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Composite_gangliocytoma/neuroma_and_neuroendocrine_tumour|Composite gangliocytoma/neuroma and neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Lipoma|Lipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Benign_vascular_tumours|Benign vascular tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:PEComa|PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Glomangioma_and_glomus_tumour|Glomangioma and glomus tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Leiomyoma|Leiomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Rhabdomyosarcomas|Rhabdomyosarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Schwannoma|Schwannoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 10 (HAEMATOLYMPHOID TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:IgG4-related_disease|IgG4-related disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Extranodal_marginal_zone_lymphoma|Extranodal marginal zone lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 11 (GERM CELL TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Germ_cell_tumours_in_endocrine_organs|Germ cell tumours in endocrine organs]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Teratomas_with_endocrine_differentiation|Teratomas with endocrine differentiation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 12 (METASTASIS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Metastasis_to_the_pituitary_gland|Metastasis to the pituitary gland]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Metastasis_to_the_thyroid_gland|Metastasis to the thyroid gland]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Metastasis_to_the_adrenal_gland|Metastasis to the adrenal gland]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
==== CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS) ====
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_1|Multiple endocrine neoplasia type 1]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_4|Multiple endocrine neoplasia type 4]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_5_(MAX-related_tumours)|Multiple endocrine neoplasia type 5 (MAX-related tumours)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[ENDO5:SDH-deficient_tumour_syndromes|SDH-deficient tumour syndromes]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[ENDO5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[ENDO5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:McCune-Albright_syndrome|McCune-Albright syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:DICER1_syndrome|DICER1 syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[ENDO5:Glucagon_cell_hyperplasia_and_neoplasia|Glucagon cell hyperplasia and neoplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:MAFA-related_familial_insulinomatosis|MAFA-related familial insulinomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Syndromic_familial_follicular_cell-derived_thyroid_tumours|Syndromic familial follicular cell-derived thyroid tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Non-syndromic_familial_follicular_cell-derived_thyroid_tumours|Non-syndromic familial follicular cell-derived thyroid tumours]]
 
|Disease
 
|Disease
 
|
 
|

Latest revision as of 14:08, 10 September 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Endocrine and Neuroendocrine Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (PITUITARY TUMOURS)
Somatotroph PitNET/adenoma Disease
Mammosomatotroph PitNET/adenoma Disease
Lactotroph PitNET/adenoma Disease
Thyrotroph PitNET/adenoma Disease
Mature plurihormonal PIT1-lineage PitNET/adenoma Disease
Immature PIT1-lineage PitNET/adenoma Disease
Acidophil stem cell PitNET/adenoma Disease
Mixed somatotroph-lactotroph PitNET/adenoma Disease
Corticotroph PitNET/adenoma Disease
Gonadotroph PitNET/adenoma Disease
Null cell PitNET/adenoma Disease
Plurihormonal PitNET/adenomas Disease
Multiple synchronous PitNET/adenomas of distinct lineages Disease
Metastatic PitNET Disease
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituitary blastoma Disease
Pituicytomas Disease
Gangliocytoma and mixed gangliocytoma-PitNET/adenoma Disease
Sellar neurocytoma Disease
Meningiomas Disease
Chordoma Disease

CHAPTER 3 (THYROID TUMOURS)
Thyroglossal duct cyst Disease
Other congenital thyroid abnormalities Disease
Thyroid follicular nodular disease Disease
Follicular thyroid adenoma Disease
Follicular thyroid adenoma with papillary architecture Disease
Oncocytic adenoma of the thyroid Disease
Non-invasive follicular thyroid neoplasm with papillary-like nuclear features Disease
Thyroid tumours of uncertain malignant potential Disease
Hyalinizing trabecular tumour Disease
Follicular thyroid carcinoma Disease
Invasive encapsulated follicular variant of papillary thyroid carcinoma Disease
Papillary thyroid carcinoma Disease
Oncocytic carcinoma of the thyroid Disease
High-grade follicular cell-derived non-anaplastic thyroid carcinoma Disease
Anaplastic thyroid carcinoma Disease
Medullary thyroid carcinoma Disease
Mixed medullary and follicular cell-derived thyroid carcinomas Disease
Mucoepidermoid carcinoma Disease
Secretory carcinoma Disease
Sclerosing mucoepidermoid carcinoma with eosinophilia Disease
Cribriform morular thyroid carcinoma Disease
Thymoma Disease
Spindle epithelial tumour with thymus-like elements Disease
Intrathyroidal thymic carcinoma Disease
Thyroblastoma Disease

CHAPTER 4 (PARATHYROID TUMOURS)
Parathyroid hyperplasia Disease
Parathyroid adenoma Disease
Parathyroid lipoadenoma Disease
Atypical parathyroid tumour Disease
Parathyroid carcinoma Disease

CHAPTER 5 (ADRENAL GLAND TUMOURS)
Adrenal rests Disease
Adrenal cysts Disease
Adrenal myelolipoma Disease
Congenital adrenal hyperplasia Disease
Adrenocortical nodular disease Disease
Adrenal cortical adenoma Disease
Adrenal cortical carcinoma Disease
Adrenal sex cord stromal tumour Disease
Adenomatoid tumour Disease
Adrenal melanoma Disease

CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS)
Neuroblastoma Disease
Ganglioneuroblastoma, intermixed Disease
Ganglioneuroblastoma, nodular Disease
Ganglioneuroma Disease
Phaeochromocytoma Disease
Sympathetic paraganglioma Disease
Parasympathetic paraganglioma Disease
Composite phaeochromocytomas and paragangliomas Disease

CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS)
Non-functioning (non-syndromic) pancreatic neuroendocrine tumours Disease
Insulinoma Disease
Glucagonoma Disease
Somatostatinoma Disease
Gastrinoma Disease
VIPoma Disease
Serotonin-producing tumours with and without carcinoid syndrome Disease
Other pancreatic neuroendocrine tumours with ectopic hormone production Disease
Pancreatic neuroendocrine carcinoma Disease
Mixed ductal adenocarcinoma-neuroendocrine neoplasms Disease
Mixed acinar-neuroendocrine carcinoma Disease

CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS)
Neuroendocrine tumours Disease
Small cell neuroendocrine carcinoma Disease
Large cell neuroendocrine carcinoma Disease
Merkel cell carcinoma Disease
Mixed neuroendocrine-non-neuroendocrine neoplasms Disease
Composite gangliocytoma/neuroma and neuroendocrine tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease

CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS)
Lipoma Disease
Solitary fibrous tumour Disease
Benign vascular tumours Disease
PEComa Disease
Glomangioma and glomus tumour Disease
Angiosarcoma Disease
Leiomyoma Disease
Leiomyosarcoma Disease
Rhabdomyosarcomas Disease
Schwannoma Disease
Neurofibroma Disease
Granular cell tumour Disease
Malignant peripheral nerve sheath tumour Disease

CHAPTER 10 (HAEMATOLYMPHOID TUMOURS)
IgG4-related disease Disease
Extranodal marginal zone lymphoma Disease
Diffuse large B-cell lymphoma Disease
Langerhans cell histiocytosis Disease
Rosai-Dorfman disease Disease
Erdheim-Chester disease Disease
Follicular dendritic cell sarcoma Disease

CHAPTER 11 (GERM CELL TUMOURS)
Germ cell tumours in endocrine organs Disease
Teratomas with endocrine differentiation Disease

CHAPTER 12 (METASTASIS)
Metastasis to the pituitary gland Disease
Metastasis to the thyroid gland Disease
Metastasis to the adrenal gland Disease

CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS)
Multiple endocrine neoplasia type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Multiple endocrine neoplasia type 2 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Multiple endocrine neoplasia type 4 Disease
Multiple endocrine neoplasia type 5 (MAX-related tumours) Disease
Hyperparathyroidism-jaw tumour syndrome Disease
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
SDH-deficient tumour syndromes Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Carney complex Disease
McCune-Albright syndrome Disease
DICER1 syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Glucagon cell hyperplasia and neoplasia Disease
MAFA-related familial insulinomatosis Disease
Syndromic familial follicular cell-derived thyroid tumours Disease
Non-syndromic familial follicular cell-derived thyroid tumours Disease
Retrieved from "https://ccga.io/index.php?title=ENDO5:Volunteer_Assignments_and_Opportunities&oldid=15423"